Research failed to show benefits of reducing bad cholesterol – study

The study was criticised by other scientists who said its conclusions were based on “flawed analysis”

The study said that dozens of randomised controlled trials of low-density lipoprotein (LDL) cholesterol reduction through cholesterol-reducing drugs such as statins have failed to show any consistent benefit.

Decades of research has failed to show any benefit to setting targets to lower “bad” cholesterol in order to ward off heart disease and death, a new analysis has found.

The study, published in the BMJ Evidence Based Medicine on Monday, said that dozens of randomised controlled trials of low-density lipoprotein (LDL) cholesterol reduction through cholesterol-reducing drugs such as statins have failed to show any consistent benefit.